• Biophytis flagged a delay in publishing its 2025 annual financial statements, missing its previously announced reporting timetable.
• Year-end close work remains unfinished, including consolidation tasks, delaying the start of the statutory audit process.
• The delay risks a trading suspension by Euronext under market rules if the annual report is not filed on time.
• The annual general meeting will not be held within the legal deadline; a new meeting date will be set later.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.